Lomond Therapeutics Holdings, Inc.
Clinical trials sponsored by Lomond Therapeutics Holdings, Inc., explained in plain language.
-
New drug ZE50-0134 tested in healthy people for first time
Knowledge-focused CompletedThis early-stage study tested a new drug called ZE50-0134 in 104 healthy adults aged 18 to 55. The main goal was to check the drug's safety and how the body processes it, not to treat any disease. Participants took single or multiple doses by mouth, and some also took a stomach-a…
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated May 12, 2026 13:44 UTC
-
First human tests of ZE46-0134 drug completed safely
Knowledge-focused CompletedThis early-stage study tested a new drug called ZE46-0134 in 112 healthy volunteers to see if it is safe and how the body handles it. The drug is being developed for a type of blood cancer called AML. The study is now complete, and the results will help decide if further testing …
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC